United States · Bill · S
S. 1455 (114th)
TREAT Act
Introduced
22 May 2015
Last action
27 April 2016 · Reported
Status
Placed on Senate Legislative Calendar under General Orders. Calendar No. 441.
Sponsors
Edward Markey, Rand Paul, Sen. Feinstein, Dianne [D-CA], Richard Durbin, Sen. Hirono, Mazie K. [D-HI], Sen. Brown, Sherrod [D-OH], Tammy Baldwin, Sen. Franken, Al [D-MN], Sen. Casey, Robert P., Jr. [D-PA], Jeanne Shaheen, Angus King, Sen. Leahy, Patrick J. [D-VT], Bernie Sanders, Susan Collins, Jeff Merkley, John Reed, Christopher Murphy, Sen. Menendez, Robert [D-NJ], Sen. Hatch, Orrin G. [R-UT], Kirsten Gillibrand, Richard Blumenthal
Subjects
Healthcare
Source updated
5 December 2025
Summary
Recovery Enhancement for Addiction Treatment Act or the TREAT Act Amends the Controlled Substances Act to increase the number of patients that a qualifying practitioner dispensing narcotic drugs for maintenance or detoxification treatment is initially allowed to treat from 30 to 100 patients per year. Allows a qualifying physician, after one year, to request approval to treat an unlimited number of patients under specified conditions, including that he or she: (1) agrees to fully participate in the Prescription Drug Monitoring Program of the state in which the practitioner is licensed, (2) practices in a qualified practice setting, and (3) has completed at least 24 hours of training regarding treatment and management of opiate-dependent patients for substance use disorders provided by specified organizations. Revises the definition of a "qualifying practitioner" to include: (1) a physician who holds a board certification from the American Board of Addiction Medicine; and (2) a nurse practitioner or physicians assistant who is licensed under state law to prescribe schedule III, IV, or V medications for pain, who has specified training or experience that demonstrates specialization in the ability to treat opiate-dependent patients, who practices under the supervision of, or prescribes opioid addiction therapy in collaboration with, a licensed physician who holds an active waiver to prescribe schedule III, IV, or V narcotic medications for opioid addiction therapy, and who practices in a qualified practice setting. Directs the Comptroller General to initiate an evaluation of the effectiveness of this Act, including an evaluation of: (1) changes in the availability and use of medication-assisted treatment for opioid addiction, (2) the quality of medication-assisted treatment programs, (3) diversion of opioid addiction treatment medication, and (4) changes in state or local policies and legislation relating to opioid addiction treatment.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 May 2015
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
22 May 2015
Introduced
Introduced in Senate
Source: IntroReferral
16 March 2016
Reported
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Source: Committee
27 April 2016
Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 441.
Source: Calendars
27 April 2016
Reported
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Source: Committee
27 April 2016
Reported
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Reported to Senate · 27 April 2016 · Official file
- Introduced in Senate · 22 May 2015 · Official file
Documents
6 official files
Reported to Senate (text)
Reported to Senate (text)
Reported to Senate · EN · 27 April 2016
Reported to Senate (PDF)
Reported to Senate · EN · 27 April 2016
Reported to Senate with amendment(s)
summary · EN · 27 April 2016
Introduced in Senate (text)
Introduced in Senate · EN · 22 May 2015
Introduced in Senate (PDF)
Introduced in Senate · EN · 22 May 2015
Introduced in Senate
summary · EN · 22 May 2015
Sponsors
- Edward Markey · D · Sponsor
- Rand Paul · R · Sponsor
- Sen. Feinstein, Dianne [D-CA] · D · Sponsor
- Richard Durbin · D · Sponsor
- Sen. Hirono, Mazie K. [D-HI] · D · Sponsor
- Sen. Brown, Sherrod [D-OH] · D · Sponsor
- Tammy Baldwin · D · Sponsor
- Sen. Franken, Al [D-MN] · D · Cosponsor
- Sen. Casey, Robert P., Jr. [D-PA] · D · Cosponsor
- Jeanne Shaheen · D · Cosponsor
- Angus King · I · Cosponsor
- Sen. Leahy, Patrick J. [D-VT] · D · Cosponsor
- Bernie Sanders · I · Cosponsor
- Susan Collins · R · Cosponsor
- Jeff Merkley · D · Cosponsor
- John Reed · D · Cosponsor
- Christopher Murphy · D · Cosponsor
- Sen. Menendez, Robert [D-NJ] · D · Cosponsor
- Sen. Hatch, Orrin G. [R-UT] · R · Cosponsor
- Kirsten Gillibrand · D · Cosponsor
- Richard Blumenthal · D · Cosponsor
- · sshr00 · Standing
Related records
- related to → Increasing the Safety of Prescription Drug Use Act of 2015
- related to → TREAT Act
- related to ← Comprehensive Behavioral Health Reform and Recovery Act of 2016
- related to ← Heroin and Prescription Drug Abuse Prevention and Reduction Act
- related to ← Heroin and Prescription Drug Abuse Prevention and Reduction Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/senate-bill/1455
- Open data entity: https://api.congress.gov/v3/bill/114/s/1455
- us · 114-s-1455 · source updated 5 December 2025